-
Diminazene Aceturate Research Workflows
2026-09-15
Diminazene Aceturate supports two distinct research paths: trypanocidal testing in parasite models and pathway-focused ACE2 activation research. This practical guide connects formulation, assay design, mitochondrial readouts, controls, and troubleshooting without treating preclinical findings as clinical evidence.
-
Luminescent ATP Detection Assay Kit for UC Research
2026-09-15
Learn how to use a firefly luciferase ATP assay to connect ATP status with the NOX2/ROS/mitochondria/NLRP3 biology of experimental ulcerative colitis. The workflow covers cells, colon tissue, calibration, normalization, downstream protein analysis, and troubleshooting without harsh acid extraction.
-
4-MUG for Translational Lysosomal Enzyme Research
2026-09-14
Discover how 4-Methylumbelliferyl-β-D-Glucopyranoside converts glycosidase activity into a decision-ready fluorescence signal. This guide connects assay design with GBA1-mRNA research, lysosomal biology, and translational interpretation.
-
ARCA EGFP mRNA for Reliable Transfection
2026-09-14
Learn how ARCA EGFP mRNA (SKU R1001) can serve as a direct fluorescence reporter and mRNA transfection control in mammalian cell workflows. This scenario-based guide connects assay design, handling, interpretation, and supplier evaluation to more reproducible gene-expression measurements.
-
Taltirelin Inhibits Acute and Chronic Itch in Mice
2026-09-13
A 2024 study shows that the long-acting TRH analog Taltirelin suppresses both chloroquine-evoked acute scratching and diphenylcyclopropenone-associated chronic scratching in mice. The work extends Taltirelin biology beyond pain-related studies and provides a behavioral framework for evaluating centrally acting antipruritic candidates.
-
TDP43, OXPHOS, and EGFR-TKI Resistance in TNBC
2026-09-12
This 2026 study identifies TDP43 as a metabolic regulator of EGFR-TKI resistance in triple-negative breast cancer, linking its mitochondrial translocation to oxidative phosphorylation and breast cancer stem-cell enrichment. The work also positions atovaquone as a repurposing candidate that may restore EGFR-TKI sensitivity by suppressing the TDP43–OXPHOS axis, although further translational validation is required.
-
HSP90 Regulation of RNA Foci in DM1
2026-09-12
A small-molecule screen in myotonic dystrophy type 1 myoblasts identified HSP90 as a regulator of pathogenic DMPK mRNA and CUGexp RNA foci. The study further connects this effect to p-STAT3 in undifferentiated cells while showing that differentiation reverses the response, highlighting cell state as a critical experimental variable.
-
Rucaparib and the Splicing-Repair Frontier
2026-09-11
Rucaparib (AG-014699, PF-01367338) offers a precise pharmacologic lens for studying PARP1, persistent DNA damage, and radiosensitivity. By connecting established prostate cancer models with new evidence on SmD2 acetylation and BRCA1/FANC splicing in hepatocellular carcinoma, this article presents a translational framework for biomarker-led PARP inhibitor research.
-
Making CYP2C19 Metabolism More Human-Relevant
2026-09-11
A translational framework for using (S)-Mephenytoin as a mechanistically interpretable CYP2C19 substrate across recombinant enzyme assays and hiPSC-derived intestinal organoids, while preserving the boundaries between validated evidence and forward-looking workflow design.
-
Omega-3s, Glymphatic Clearance, and Sevoflurane
2026-09-10
This study links repeated neonatal sevoflurane exposure to impaired glymphatic transport, phosphorylated tau accumulation, mitochondrial dysfunction, and later cognitive and fine motor abnormalities. Its central innovation is the identification of omega-3 polyunsaturated fatty acids as a maternal dietary intervention that preserves AQP4 polarization through PDGF-B/PDGFRβ signaling and improves phosphorylated tau clearance.
-
Berberine Hydrochloride: From AMPK to the Gut-Bone Axis
2026-09-10
Berberine hydrochloride is moving beyond a conventional metabolic research reagent. New evidence connects its microbiome-modulating activity with butyrate, GPR41, intestinal tuft cells, barrier integrity, and osteoimmune balance. This thought-leadership article translates those findings into a practical framework for metabolic, microbiome, bone, and translational research while distinguishing mechanistic promise from clinical readiness.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-09-09
A 2025 study found that selected naturally occurring angiotensin peptides enhance SARS-CoV-2 spike binding to AXL, ACE2, and NRP1, with peptide length and Tyr4 modification governing activity. The results connect renin-angiotensin system peptide processing with viral receptor biology, while remaining preliminary because the work used binding assays rather than infection or in vivo disease models.
-
GI 254023X: ADAM10 Inhibitor Workflows
2026-09-09
GI 254023X enables selective interrogation of ADAM10 sheddase activity in Jurkat signaling and endothelial barrier models. This workflow-focused guide connects target engagement with Notch1, VE-cadherin, toxin-challenge, and functional readouts while emphasizing exposure control and assay troubleshooting.
-
CFDA SE Cell Tracer Kit: Practical Guide
2026-09-08
The CFDA SE Cell Tracer Kit provides persistent fluorescent labeling for cell lineage tracing, cell proliferation studies, and related in vitro or in vivo tracking workflows. It is best suited to multi-day monitoring with covalent dye retention, but it is not the preferred choice for reversible, short-term, or real-time labeling applications.
-
Palbociclib Nanocrystal Gel for Local Breast Cancer Therapy
2026-09-08
The reference study combines palbociclib nanocrystals with a thermoresponsive poloxamer gel to address poor solubility and improve localized drug exposure in breast cancer models. Its findings connect nanoscale formulation, sustained intratumoral release, cellular uptake, oxidative stress, migration, and apoptosis-related responses, while also identifying important questions for translational validation.